Meta‐analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro‐oesophageal junctional cancers

No abstract is available for this paper.

• Publication year

  2014

• Venue

  British Journal of Surgery

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/bjs.9418PMID 24493117
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of neoadjuvant chemoradiotherapy on airway colonization and postoperative respiratory complications in patients undergoing oesophagectomy for oesophageal cancer.

  2012cited by this paper
• Preoperative chemoradiotherapy for esophageal or junctional cancer.

  2012cited by this paper
• Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.

  2011cited by this paper
• Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: Long-term results of a randomized controlled trial

  2011cited by this paper
• Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

  2011cited by this paper
• Transthoracic Versus Transhiatal Esophagectomy for the Treatment of Esophagogastric Cancer: A Meta-Analysis

  2011cited by this paper
• Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial.

  2011cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

  2010cited by this paper
• Open versus minimally invasive esophagectomy: a single-center case controlled study

  2010cited by this paper
• Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma.

  2010cited by this paper
• Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma.

  2009cited by this paper
• Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction.

  2009cited by this paper
• Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer.

  2009cited by this paper
• Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews

  2009cited by this paper
• Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis.

  2009cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma.

  2009cited by this paper
• Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

  2008cited by this paper
• Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)

  2008cited by this paper
• Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

  2007cited by this paper
• Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities.

  2007cited by this paper
• Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.

  2007cited by this paper
• Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution.

  2006cited by this paper
• Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

  2006cited by this paper
• Preoperative chemotherapy for resectable thoracic esophageal cancer.

  2006cited by this paper
• Indirect comparisons of competing interventions.

  2005cited by this paper
• Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

  2005cited by this paper
• A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma.

  2004cited by this paper
• Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey

  2004cited by this paper
• Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.

  2003cited by this paper
• Neoadjuvant Treatment for Resectable Cancer of the Esophagus and the Gastroesophageal Junction: A Meta-Analysis of Randomized Clinical Trials

  2003cited by this paper
• A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.

  2002cited by this paper
• Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial.

  2002cited by this paper
• Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival.

  2002cited by this paper
• Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.

  2001cited by this paper
• Cancer burden in the year 2000. The global picture.

  2001cited by this paper
• Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma

  2001cited by this paper
• Prospective evaluation of preoperative chemotherapy in resectable squamous cell carcinoma of the thoracic esophagus.

  2000cited by this paper
• Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

  1999cited by this paper
• Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.

  1998cited by this paper
• Fraction size and dose parameters related to the incidence of pericardial effusions.

  1998cited by this paper
• Chemotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus

  1998cited by this paper
• Changing patterns in the incidence of esophageal and gastric carcinoma in the United States

  1998cited by this paper
• Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial.

  1997cited by this paper
• Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.

  1997cited by this paper
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

  1996cited by this paper
• Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: A prospective randomized study

  1995cited by this paper
• Operating characteristics of a rank correlation test for publication bias.

  1994cited by this paper
• A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus

  1994cited by this paper
• Induction chemotherapy in the treatment of patients with carcinoma of the esophagus

  1994cited by this paper
• A prospective study of combined therapy in esophageal cancer.

  1994cited by this paper
• Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer

  1992cited by this paper
• Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group.

  1992cited by this paper
• Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus.

  1988cited by this paper

• Causes of death in locally advanced esophageal cancer undergoing neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy: a retrospective cohort study.

  2025cites this paper
• Neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma in real-world practice: an analysis of the clinical outcomes and long-term survival, and the feasibility of using major pathological response as a surrogate endpoint

  2025cites this paper
• Risk and protective factors for postoperative anastomotic leakage in esophageal and gastrointestinal surgery: an umbrella review of meta-analyses and systematic reviews

  2025cites this paper
• Prediction of esophagogastric anastomotic leakage by nomogram combined with preoperative nutritional status and clinical factors: a retrospective study of 775 patients

  2025cites this paper
• The efficacy and safety of adjuvant immunotherapy after neoadjuvant immunotherapy combined with chemotherapy in locally advanced resectable esophageal squamous cell carcinoma: a real−world study

  2025cites this paper
• Recurrence patterns and long-term survival of locally advanced esophageal cancer patients with pathological complete response after different neoadjuvant therapies followed by surgery

  2025cites this paper
• Neoadjuvant immunochemotherapy for resectable esophageal cancer: A study on efficacy and safety

  2025cites this paper
• Mechanistic insights into fibroblasts in neoadjuvant therapy for esophageal squamous cell carcinoma

  2025cites this paper
• Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma

  2025cites this paper
• Preoperative radiotherapy in patients with locally advanced esophageal squamous cell carcinoma: a narrative review

  2025cites this paper
• Risk factors and prediction of intensive care unit readmission after esophagectomy for cancer.

  2025cites this paper
• Efficacy and safety of neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in locally advanced esophageal cancer: An updated meta-analysis

  2024cites this paper
• Phase III randomized trial comparing neoadjuvant paclitaxel+platinum to 5-fluorouracil+platinum in esophageal/GEJ squamous cell carcinoma.

  2024cites this paper
• S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus

  2024cites this paper
• Neoadjuvant radiation target volume definition in esophageal squamous cell cancer: a multicenter recommendations from Chinese experts

  2024cites this paper
• A2HTL: An Automated Hybrid Transformer-Based Learning for Predicting Survival of Esophageal Cancer Using CT Images

  2024cites this paper
• Survival outcomes of neoadjuvant immunochemotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma

  2024cites this paper
• Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction

  2024cites this paper
• Treatment and survival analysis for 40-year SEER data on upper esophageal cancer

  2023cites this paper
• To compare neoadjuvant concurrent chemo-radiotherapy followed by surgery and neoadjuvant chemotherapy followed by surgery in carcinoma esophagus patients: A single institutional study in the Indian population

  2023cites this paper
• The effect of gastric fundus radiation dose on postoperative anastomotic leakage in esophageal cancer

  2023cites this paper
• Current neoadjuvant therapy for operable locally advanced esophageal cancer

  2023cites this paper
• The effect of anastomotic leakage on the incidence of recurrence after tri‐modality therapy for esophageal adenocarcinomas

  2023cites this paper
• A Fully Automated CT-Guided Learning for Survival Prediction of Esophageal Cancer

  2023cites this paper
• Preoperative administration of camrelizumab combined with chemotherapy for borderline resectable esophageal squamous cell carcinoma (BRES-1): study protocol of a single-arm, open-label, phase II study

  2023cites this paper
• Therapeutic evaluation of postoperative chemotherapy and chemoradiotherapy on cardiopulmonary complications in patients with esophageal squamous cell carcinoma

  2023cites this paper
• Concurrent radiotherapy cannot provide superiority of surgical oncological outcome and long-term survival rate in locally advanced esophageal squamous cell carcinoma patients receiving neoadjuvant chemotherapy followed by minimally invasive esophagectomy

  2023cites this paper
• Postoperative complications after esophagectomy for cancer, neoadjuvant chemoradiotherapy compared to neoadjuvant chemotherapy: A single institutional cohort study

  2023cites this paper
• Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from A Japanese Nationwide Study

  2023cites this paper
• A Transcriptomic Liquid Biopsy Assay for Predicting Resistance to Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma

  2022cites this paper
• Efficacy and Safety of Neoadjuvant Chemoimmunotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Meta-analysis

  2022cites this paper
• Neoadjuvant Anlotinib and chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced esophageal squamous cell carcinoma: Short-term results of an open-label, randomized, phase II trial

  2022cites this paper
• Surgical Treatment of Patients with Adenocarcinoma of the Distal Esophageal Portion and Gastroesophageal Junction Performed After Neoadjuvant Chemotherapy and Combined Chemoradiation

  2022cites this paper
• Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE)

  2022cites this paper
• Does Neoadjuvant Radiation Therapy Contribute to the Incidence of Pulmonary Complications Following Esophagectomy for Malignant Neoplasm?

  2022cites this paper
• Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: A prospective multi-center randomized clinical trial.

  2022cites this paper
• Ulcer Scarring in the Gastric Conduit Is a Risk Factor for Anastomotic Leakage After Esophagectomy for Esophageal Cancer

  2022cites this paper
• The Feasibility of Early Oral Feeding After Neoadjuvant Chemotherapy Combined With “Non-Tube No Fasting”-Enhanced Recovery

  2022cites this paper
• Feasibility, safety and oncological outcomes of minimally invasive oesophagectomy following neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma – Experience from a tertiary care centre

  2022cites this paper
• CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: a multicenter study.

  2022cites this paper
• Quantitative RECIST derived from multiparametric MRI in evaluating response of esophageal squamous cell carcinoma to neoadjuvant therapy

  2022cites this paper
• Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Perioperative and Survival Outcomes

  2022cites this paper
• Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma

  2022cites this paper
• Development and Validation of a New Integrative Score Based on Various Systemic Inflammatory and Nutritional Indicators in Predicting Prognosis in Patients With Resectable Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study

  2022cites this paper
• Proton Beam Therapy for Esophageal Cancer

  2022cites this paper
• AGR2 expression as a predictive biomarker for therapy response in esophageal squamous cell carcinoma

  2022cites this paper
• Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

  2021cites this paper
• Effects of SLC31A1 and ATP7B polymorphisms on platinum resistance in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiotherapy

  2021cites this paper
• End to end intussusception anastomosis decreases the risk of anastomotic leakage after neoadjvant chemoradiation and McKeown oesophagectomy.

  2021cites this paper
• Safety of Neoadjuvant Chemoradiotherapy Followed by Surgery for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma.

  2021cites this paper
• Neoadjuvant treatment in esophageal cancer—established treatments and new developments reviewed

  2021cites this paper
• Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives

  2021cites this paper
• Development and validation of a novel pre-operative comprehensive prognostic score in esophageal squamous cell carcinoma

  2021cites this paper
• Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Where we Stand; An Italian Single Center Perspective

  2021cites this paper
• Preliminary evaluation of postoperative radiotherapy with small T-shaped field in thoracic esophageal squamous cell carcinoma.

  2021cites this paper
• A multicenter single-arm trial of sintilimab in combination with chemotherapy for neoadjuvant treatment of resectable esophageal cancer (SIN-ICE study)

  2021cites this paper
• Role of chemotherapy after curative esophagectomy in squamous cell carcinoma of the thoracic esophagus: A propensity score‐matched analysis

  2021cites this paper
• Clinical Target Volume Auto-Segmentation of Esophageal Cancer for Radiotherapy After Radical Surgery Based on Deep Learning

  2021cites this paper
• Nanopoxia: Targeting Cancer Hypoxia by Antimonene‐Based Nanoplatform for Precision Cancer Therapy

  2021cites this paper
• Treatment and Survival Analysis for 40-year SEER Data on Upper Esophageal Cancer

  2021cites this paper
• Frequency of different histopathological types of esophageal cancer patients at oncology department of a tertiary care hospital in Karachi

  2021cites this paper
• Optimal Treatment of cT2N0 Esophageal Carcinoma: Is Upfront Surgery Really the Way?

  2021cites this paper
• Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Multicenter, Single-Arm Study

  2021cites this paper
• Multidisciplinary Management of Gastroesophageal Reflux Disease

  2021cites this paper
• AGR2 – a Novel Predictor of Neoadjuvant Chemoradiotherapy Response in Esophageal Squamous Cell Carcinoma

  2021cites this paper
• Residual tumor characteristics of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.

  2020cites this paper
• ESODATA: benchmarking esophagectomy complications

  2020cites this paper
• Role of surgery in multidisciplinary treatment strategies for locally advanced esophageal squamous cell carcinoma

  2020cites this paper
• Predictors of Anastomotic Leak After Esophagectomy for Cancer: Not All Leaks Increase Mortality

  2020cites this paper
• Can Minimally Invasive Esophagectomy Replace Open Esophagectomy for Esophageal Cancer? Latest Analysis of 24,233 Esophagectomies From the Japanese National Clinical Database.

  2020cites this paper
• Robot-Assisted Esophagectomy After Neoadjuvant Chemoradiation—Current Status and Future Prospects

  2020cites this paper
• Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline.

  2020cites this paper
• Current status of esophageal cancer treatment

  2020cites this paper
• What are the Particularities of Oesophageal Surgery in Cirrhotic Patients.

  2020cites this paper
• Esophageal cancer surgery in Greece during the era of the financial crisis.

  2020cites this paper
• Operative Results and Perioperative Morbidity After Intensified Neoadjuvant Chemotherapy with FLOT for Gastroesophageal Adenocarcinoma Impact of Intensified Neoadjuvant Treatment

  2020cites this paper
• [Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?]

  2020cites this paper
• Surgical Treatment of Esophageal Adenocarcinoma

  2020cites this paper
• Pattern of clinical response after concurrent chemoradiotherapy in patients with esophagus carcinoma

  2020cites this paper
• S3-Leitlinie – Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus

  2019influential citation
• Effects of postoperative chemotherapy on cardiopulmonary complications in patients with esophageal cancer

  2019influential citation
• Nodal Downstaging of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy: Survival Analysis if ypN0 Is Achieved

  2019cites this paper
• Cancers de l’œsophage (III). Prise en charge thérapeutique

  2019cites this paper
• Comment on "Patterns of Postoperative Visits Among Medicare Fee-for-service Beneficiaries".

  2019cites this paper
• Comparison of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for esophageal cancer: a meta-analysis.

  2019cites this paper
• Patients with Non-response to Neoadjuvant Chemoradiation for Esophageal Cancer Have No Survival Advantage over Patients Undergoing Primary Esophagectomy

  2019cites this paper
• Preoperative treatment of locally advanced gastrointenstinal cancer

  2019cites this paper
• Neoadjuvant chemotherapy followed by minimally invasive esophagectomy versus primary surgery for management of esophageal carcinoma: a retrospective study

  2019cites this paper
• Effect of neoadjuvant chemoradiation on preoperative pulmonary physiology, postoperative respiratory complications and quality of life in patients with oesophageal cancer

  2019cites this paper
• Timing of Esophagectomy after Neoadjuvant Chemoradiation Therapy Affects the Incidence of Anastomotic Leaks

  2019cites this paper
• Radiation dose mapping and anastomotic complications after trimodality therapy for esophageal cancers

  2019cites this paper
• The role of neoadjuvant chemoradiotherapy vs chemotherapy in cancer of oesophagus

  2019cites this paper
• Response to Comment on ‘ ‘ Can Minimally Invasive Esophagectomy Replace Open Esophagectomy for Esophageal Cancer ? Latest Analysis of 24 , 233 Esophagectomies From the Japanese National Clinical Database

  2019cites this paper
• Cardiorespiratory Comorbidity and Postoperative Complications following Esophagectomy: a European Multicenter Cohort Study

  2019cites this paper
• Controversies in preoperative therapy in esophageal cancer: Current evidence and ongoing research

  2019cites this paper
• Utility of Radiation After Neoadjuvant Chemotherapy for Surgically Resectable Esophageal Cancer

  2019cites this paper
• Outcomes and complications after robot-assisted minimally invasive esophagectomy

  2019cites this paper
• Esophagogastric Junction (EGJ) Carcinoma: An Updated Review

  2019cites this paper
• GI Surgery Annual

  2019cites this paper
• Evaluation of the impact of psoas muscle index, a parameter of sarcopenia, in patients with esophageal squamous cell carcinoma receiving neoadjuvant therapy

  2019cites this paper